US FDA Guidance Redefines Obesity, But Keeps 2007 Efficacy Standard

 
• By Michael McCaughan
  
The FDA did not update its efficacy expectations for weight loss drugs in new draft guidance. (Shutterstock)

More from Approval Standards

More from R&D